Posted on 12/12/17
Teleflex Signs New Agreement with HealthTrust
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery has announced that its respiratory division has signed . . .
Posted on 12/11/17
Aesculap Biologics Launches New Website
Aesculap Biologics, LLC is pleased to announce the launch of its redesigned website. The new website has a clean, uncluttered design, improved functionality, and enhanced rich . . .
Posted on 11/21/17
Recro Pharma Secures $100 Million Credit Facility
MALVERN, Pa., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute . . .
Posted on 11/10/17
Onconova Therapeutics Prices Public Offering of Common Stock
NEWTOWN, Pa., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug . . .
Posted on 11/9/17
Teva: Stop 'Tucking These Away'
I've only been following the Teva Pharmaceuticals (TEVA) saga since the early August crash caught my attention, but in every article I have read the comments . . .
Posted on 11/9/17
Here's Why Merck & Co., Inc. Tanked 14% in October
What happenedShares of America's second largest pharmaceutical company, Merck & Co., Inc. (NYSE:MRK)suffered their worst month in years, falling 14% in October, according to data from . . .
Posted on 11/7/17
Healthcare Administrative Partners’ Clinical Analytics Innovation Receives Industry Recognition
MEDIA, Pa.--(BUSINESS WIRE)--Healthcare Administrative Partners (HAP), a provider of comprehensive revenue cycle management solutions for specialty physician practices, was recently selected to be one of the . . .
Posted on 11/6/17
The Cost Benefit of Health Care Transparency
As our nation seeks solutions to help improve the healthcare system, there is at least one goal we can all agree on: the importance of making . . .
Posted on 11/6/17
5 Tips To Help Americans Prepare For Open Enrollment And Save On Healthcare Costs
More than 70 percent of Americans say they are prepared for open enrollment, yet most people struggle to understand basic health insurance terms, according to a . . .
Posted on 11/6/17
AmerisourceBergen Corporation 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by AmerisourceBergen Corporation in conjunction with their 2017 Q4 earnings call. 117READ FULL ARTICLE HERE
Posted on 11/6/17
Teva Punished After Weak Outlook
Teva CEO Kare SchultzTeva (TEVA) reported Q3 revenue of $5.61 billion and eps of $1.00. The company missed on revenue by $10 million and missed on . . .
Posted on 11/6/17
Teva: Value Trap
Investment ThesisI was previously bullish Teva (TEVA) while not being a shareholder. Now, I'm totally bearish but ended up being a shareholder. Which is ironic. Teva's . . .
Posted on 11/6/17
Merck: A Slow And Steady Dividend Grower, But Do Better Alternatives Exist?
Blue chip drug makers such as Merck (NYSE:MRK) have historically been very popular with income investors because of their defensive nature, meaning that drug demand isn't . . .
Posted on 12/5/17
Interview with Mike Daley, CEO of OrthogenRx - Part III
Brought to you by Newmark Knight Frank
Posted on 11/30/17
Interview with Mike Daley, CEO of OrthogenRx - Part II
Brought to you by Newmark Knight Frank
Posted on 11/27/17
Interview with Mike Daley, CEO of OrthogenRx - Part I
Brought to you by Newmark Knight Frank
Posted on 11/6/17
Onconova Therapeutics to Provide Corporate Update
NEWTOWN, Pa., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat . . .
Posted on 11/6/17
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
MALVERN, Pa., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies . . .
Posted on 11/9/17
Interview with Steve Wray, CEO of CloudMine - Part III
Brought to you by Newmark Knight Frank
Posted on 11/7/17
Interview with Steve Wray, CEO of CloudMine - Part II
Brought to you by Newmark Knight Frank
Posted on 11/1/17
Interview with Steve Wray, CEO of CloudMine - Part I
Brought to you by Newmark Knight Frank
Posted on 10/27/17
Idera Pharmaceuticals Prices Public Offering of Common Stock
CAMBRIDGE, Mass. and EXTON, Pa. , Oct. 26, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) announced the pricing of its underwritten public offering of 33,333,334 . . .
Posted on 10/26/17
West Announces Third-Quarter 2017 Results
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2017, updated financial guidance for the full-year 2017, introduced sales . . .
Posted on 10/26/17
Mylan Wins UK Court Ruling Related to Copaxone 40 mg/mL Patent
Mylan N.V. (NASDAQ, TASE: MYL) today announced that the United Kingdom's High Court of Justice has issued a decision in favor of Mylan and its European . . .
Posted on 10/26/17
Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement
PARSIPPANY, N.J. and MALVERN, Pa., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that it has committed to invest up to $25 . . .
Pittsburgh
